Skip to main content

Argos Therapeutics Inc (NASDAQ:ARGS) Investor Securities Class Action Lawsuit 03/15/2017

  • If you purchased shares of Argos Therapeutics Inc (NASDAQ:ARGS), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

September 26, 2017 - The case was voluntarily dismissed. March 15, 2017 (Shareholders Foundation) - An investor in shares of Argos Therapeutics Inc (NASDAQ:ARGS) filed a lawsuit in the U.S. District Court for the Middle District of North Carolina over alleged violations of Federal Securities Laws by Argos Therapeutics Inc in connection with certain allegedly false and misleading state...



You must register (for free) or login to view the entire case.